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Breast cancer is the most prevalent causes of 
cancer mortality, among the female population in 
developing countries (1). Tamoxifen (TAM) is an 
anti-estrogenic drug widely used for adjuvant 
therapy in breast cancer patients (2). In addition, 
TAM is also used to prevent breast cancer in 
healthy high-risk women (3). Long term TAM 
therapy may lead to serious side effects, such as 
cardiovascular events, hepatic injury, etc. (4, 5).  
Hence, the use of herbal medicine with anti-
cancer effects, in combination with low concen-
trations of TAM may help to reduce TAM side 
effects. Lauryl gallate (LG) is a Gallic acid deriva-
tive with antioxidant effects, used as a food addi-
tive (6). LG has been proven to protect human 
cells from oxidative damage and to inhibit tumor 
growth, without affecting normal cells (7). In ad-
dition, LG has also been reported to induce 
Abstract 
Background: Tamoxifen (TAM) is widely used for adjuvant therapy in breast cancer patients. Tamoxifen ther-
apy may lead to serious side effects. Anti-apoptotic substances in combination with chemotherapy drugs can 
result in additive or synergistic effects. Lauryl gallate (LG), a Gallic acid derivative, has been proven to inhibit 
tumor growth, without affecting normal cells. This study aimed to investigate the synergistic effect of TAM and 
LG in breast cancer cell line (MCF-7).  
Methods: In this experimental study, performed in ShahreKord University of Medical Science, Iran in 2017, 
the MCF-7 cells were treated by final concentrations of 10 μM TAM alone, and in combination with 200 μM of 
LG. We also used EX-527, as SIRT-1 inhibitor to examine the role of SIRT1 in cell apoptosis. BCL-2 and 
SIRT1 gene expression were measured by real-time PCR method, and cell apoptosis was investigated by flow 
cytometry. 
Results: Tamoxifen alone and in combination with LG decreased BCL-2 expression 2.64±0.75 and 6.38±1.9 
fold, respectively, after 48 h (P<0.05). SIRT1 expression was increased 1.67±0.22 and 2.47±0.34 - fold by TAM 
alone and in combination with LG, respectively (P<0.05). TAM alone and in combination with LG increased 
the percentage of apoptotic cells 15.79±2.81 and 60.67±6.23 percent, respectively after 48 h (P<0.001).  
Conclusion: The combination of LG and TAM is more effective for induction of apoptosis of breast cancer 
cells, compared to individual use of each. Thus, our data pave the way for new therapeutic options for sup-
pressing breast cancer growth. 
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apoptosis and inhibit the proliferation of cancer 
cells (8, 9). 
The combination therapy might be a significant 
advantage for cancer patients, to increase the re-
sponse rate and reduce side effects of cancer 
therapeutics. Combination therapies, promoting 
the effectiveness of TAM, have been previously 
investigated in several studies, using compounds, 
such as caffeic acid phenethyl ester (10), green tea 
(11) and thymoquinone (12).  
Concurrent administration of LG has additive or 
synergistic effects with TAM, widely has been 
used for the treatment of breast cancer.  
Accordingly, in this study we investigated the ef-
ficacy of TAM and LG in breast cancer cells, 
with regard to apoptosis in these cells. 
 
Materials and Methods 
 
Cell culture 
In this experimental study, the human breast can-
cer cell lines MCF-7 were obtained from the Pas-
teur Institute of Iran in 2017. Cells were routinely 
maintained in RPMI medium 1640 (Sigma, USA), 
containing 10% fetal bovine serum (FBS; Gibco, 
USA), 100 U/ml penicillin and 100 mg/ml strep-
tomycin (Sigma, USA). Cells were incubated in a 
humidified incubator, containing 5% CO2 at 37 
°C. Cell growth and cell division were daily con-
trolled.  
The study protocol was approved by the 
Shahrekord University of Medical Science Ethics 
Committee (IR.SKUMS.REC.1395.98). 
 
Cell proliferation assay 
The MTT assay was used to determine LG con-
centration, causing 50% cell death (IC50). Briefly, 
the cells were seeded at a density of 15×103 in 
96-well plates, and allowed to attach for 24 h, 
before incubation with drugs.  
Cells were then exposed to different doses of LG 
alone and in combination with 10 μM final con-
centration of TAM (10), for 48 hours. For each 
sample and for every concentration three wells 
were loaded. Thereafter, 20 μl MTT (Sigma-
Aldrich; 5 mg/ml) solution was added to each 
well. After 4h incubation at 37 °C, the medium 
was replaced with 100 μL of 0.1 N 
HCl/isopropanol, in each well. The optical densi-
ty of each well was determined at 570  nm, using 
an ELISA plate reader (Awareness, USA). 
 
Treatment 
The cells were seeded in a 6-well plate at a densi-
ty of 1×105 cells per well. After 24 h, they were 
treated by 10 μM final concentration of TAM 
alone and in combination with 200 μM final con-
centration of LG, for 24 and 48 hours. Another 
group was also considered with TAM and LG, in 
combination with 2 μM final concentration of 
EX-527, as SIRT-1 inhibitor. A group was con-
sidered as control group cultured without any 
drug treatment.  We used EX-527 to examine the 
role of SIRT1 in cell apoptosis. By this, we de-
termined the contribution and role of each gene 
(BCL-2 and SIRT-1) in the apoptosis induction.  
 
RNA isolation and cDNA synthesis 
Total RNA was isolated from the cells, using Tri-
zol (Invitrogen, California), according to the 
manufacturer’s instructions. RNA was quantified, 
using a Nanodrop 2000 C spectrophotometer 
(Thermo Scientific-USA). Then cDNA was syn-
thesized from 0.4 mg total RNA, using random 
primer and the cDNA synthesis kit (Thermo 
Fisher Scientific-Waltham, MA). 
 
Real-Time Polymerase Chain Reaction (real-
time PCR) 
BCL-2 and SIRT-1 gene Expression were meas-
ured by quantitative real-time PCR. The experi-
ments were performed, using Rotor-Gene 3000 
real-time DNA amplification system (Corbett 
Research, Australia), and SYBR Green Method. 
Primers used for real-time PCR are listed in Ta-
ble 1. Experiments were performed in triplicate, 
using 5 µL SYBR Green PCR Master Mix, 0.2 µL 
primer sets (10 μMol), 40 ng cDNA, and 3.6 µL 
nuclease-free H2O, in a final volume of 10 µL. 
The amplification was carried out under the fol-
lowing conditions: initial denaturing at 95 °C for 
10 min, then 40 cycles of 95 °C for 15 sec, 59 °C 
for 20 sec and 72 °C for 25 sec. Quantitation of 
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data was performed, using the comparative ex-
pression CT (ΔΔCT) method. GAPDH was used 
as a housekeeping gene. The gel electrophoresis 
of PCR product and melting curve analysis were 
investigated to ensure the specificity of the reac-
tions.
 
Table 1: Primer sequences and product length 
 





BCL-2 Forward: GTGCTGAAGATTGATGGGATCG 
Reverse: TCAGTCTACTTCCTCTGTGATGTTG 
118 NM_000633.2 








Flow cytometric analysis of cell apoptosis  
The apoptosis kit (FITC Annexin V Apoptosis 
Detection Kit I, BD Biosciences, USA) was used 
to detect the apoptotic cells, according to the 
manufacturer’s recommendation. Briefly, MCF-7 
cells were seeded in the 6-well plates (1 × 105 
cells per well) and incubated for 24 hours. Then 
they were treated similar to those previously 
mentioned. After 24 h and 48 h, the cells were 
trypsinized and washed in PBS. Overall, 100 μL 
of cells were transferred to a tube, 5 μL of FITC-
conjugated Annexin V (Annexin V-FITC) and 5 
μL of propidium iodide (PI) were added, fol-
lowed by incubation for 15 min at room tempera-
ture, in the dark. The cells were diluted by the 
binding buffer and directly analyzed, using flow 
cytometry (Partec GmbH, Munster, Germany). 
Statistical analysis 
All experiments were performed in triplicate. Da-
ta are expressed as mean±SEM. Statistical analy-
sis was performed, using nonparametric Kruskal-
Wallis test. Differences between two groups were 
investigated by the Mann-Whitney test. P<0.05 




Cell viability in MCF-7 cell line was determined 
by MTT assay (Fig. 1). The IC50 of the LG and 
in combination with 10 μM TAM was about 200 
μmol/L. This concentration of LG was chosen 





Fig. 1: Cell viability in MCF-7 cell line. Effect of different doses of lauryl gallate (LG) alone and in combination with 10 μM 
tamoxifen (TAM) on cell viability, were determined by MTT assay for 48 hours. Data are presented as mean ± SEM of three 
independent experiments *P<0.05, **P<0.01 
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We investigated the LG effects on BCL-2 and 
SIRT-1 expression in MCF-7 cells, in combina-
tion with TAM and EX-527(inhibitor of SIRT1), 
after 24 h and 48 hours. Our results showed 
TAM alone and in combination with 200 μM of 
LG significantly decreased BCL-2 expression 2.64 
± 0.75 and 6.38±1.9 –fold after 48 h, respective-
ly, compared with the control group (P<0.001) 
(Fig. 2A). An increase in BCL-2 expression was 
achieved when SIRT1 was inhibited by EX-527 
(P<0.05). 
After 48h, SIRT1 expression was significantly 
increased 1.67±0.22 and 2.47±0.34 fold by TAM 
alone and in combination with 200 μM of LG, 
respectively (P<0.05) (Fig. 2B). EX527 inhibited 
deacetylase activity of SIRT1 in MCF-7 cell lines 
and thereby SIRT1 expression was decreased 




Fig. 2: BCL-2 and SIRT1 gene expression in MCF-7 cells, after 24 and 48 hours 
TAM: Tamoxifen (10 μM), TAM+LG: Tamoxifen (10 μM) in combination with 200 μM of LG. TAM+LG+EX-527: Tamoxi-
fen (10 μM) in combination with 200 μM of LG and 2 μM EX-527 
Data are presented as mean ± SEM of three independent experiments. *Compared to the control group, # compared to TAM + 
LG group 
 
We further investigated the extent of apoptosis, 
by determining the percentage of Annexin V-
stained cells. TAM alone and in combination 
with 200 μM of LG increased the percentage of 
apoptotic cells to 15.79±2.81% and 
60.67±6.23%, respectively, after 48 h (Fig. 3) 
(P<0.001). On the other hand, the increase in 
apoptosis was reduced by EX-527, as SIRT1 in-
hibitor (P<0.05). However, by SIRT1 inhibition, 




In this study, LG, as an antioxidant plays a role in 
reducing the growth of breast cancer cells. It 
does this by enhancing apoptosis through down-
regulation of the anti-apoptotic gene expression, 
such as BCL-2. 
The complex biology of cancer development re-
quires relatively complex treatment approaches. 
Thus, the application of synergistic combinations 
of drugs, play an important role in the treatment 
of cancer (13).  
In this study, the combination of LG and TAM is 
more potent, compared to either agent alone, in 
preventing breast cancer cell growth. This pre-
vention occurs through apoptotic effects of LG 
and TAM. 
Anti-apoptotic substances in combination with 
chemotherapy drugs can result in additive or syn-
ergistic effects. For example, the combination of 
green tea and TAM have a synergistic effect on 
inhibiting the growth of cancer cell (11). Moreo-
ver, curcumin in combination with TAM may 
have therapeutic benefit for prevention of breast 
cancer cells growth (14). 
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Fig. 3: Flow cytometry analysis of Annexin V-FITC/PI stained apoptotic cells. A). Dot plot profile of cells after 48 h. B) Bar diagram of per-
cent apoptotic cells after 24 and 48 hours 
TAM: Tamoxifen (10 μM), TAM+LG: Tamoxifen (10 μM) in combination with 200 μM of lauryl gallate. TAM+LG+EX-527: Tamoxifen (10 
μM) in combination with 200 μM lauryl gallate and 2 μM EX-527 
Data are presented as mean ± SEM of three independent experiments. *Compared to the control group, # compared to TAM + LG group 
 
LG is a Gallic acid derivative with antioxidant 
effects, used as a food additive. It may be possi-
ble to use lower doses of chemical drugs and 
minimize the associated side effects, by using 
concurrent intake of herbal medicine that has 
fewer side effects, compared to chemotherapy 
drugs.  
The synergistic effects of other chemotherapy 
drugs with Gallic acid derivative have also been 
reported in a study (15). Dhima et al. have shown 
pre-treatment with epigallocatechin-3-gallate 
(EGCG) sensitised leiomyosarcoma cells to cis-
platin (15). Overall, synergistic combinations of 
herbal medicines and chemotherapy drugs may 
use for enhancing efficacy, reducing side effects, 
immune modulation, and abrogating drug re-
sistance (13). 
SIRT1 is a member of the sirtuin family involved 
in genomic stability and cell survival, acting by 
deacetylation of histone and affecting some cell 
cycle regulators. There is a controversy about the 
role of sirtoin, as a tumor suppressor gene or as a 
proto-oncogene (16, 17).  
In our study, TAM increased the SIRT-1 gene 
expression, and LG intensified this effect. This 
effect was confirmed, by using EX527 as inhibit-
ing the activity of SIRT1. But, by SIRT1 inhibi-
tion, the apoptosis rate was decreased only about 
6%. The synergistic effects of tamoxifen and lau-
ryl gallate have a greater effect on the BCL-2 than 
SIRT1 gene at induction of apoptosis. But, it 
seems that the increase in TAM and LG -induced 
apoptosis, is partly due to the effect of SIRT-1 on 
BCL-2 expression. Kuo et al. showed that SIRT1 
suppresses breast cancer growth, through down-




Overall, compounds, such as LG strengthen the 
effects of drugs such as TAM, in inhibition of 
cancer cell growth. Further in vivo experiments 
needed, to confirm and validate these findings. 
Our data pave the way for using low-dose chem-
otherapy drugs and reducing the associated side 
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